Hlusí A - Search Results

1

[Molecular methods in thrombophilic states diagnostics].

Slavík L, Krcová V, Hlusí A, Procházková J, Ulehlová J. Slavík L, et al. Among authors: hlusi a. Vnitr Lek. 2009 Mar;55(3):302-9. Vnitr Lek. 2009. PMID: 19378863 Review. Czech.

2

Molecular pathophysiology of thrombotic states and their impact to laboratory diagnostics.

Slavik L, Krcova V, Hlusi A, Prochazkova J, Prochazka M, Ulehlova J, Indrak K. Slavik L, et al. Among authors: hlusi a. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):19-25. doi: 10.5507/bp.2009.003. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365521 Free article. Review.

3

[The occurence of genetic trombophilic markers in patients evaluated for infertility].

Filipčíková R, Březinová J, Oborná I, Blažková Z, Krčová V, Slavík L, Ulehlová J, Hluší A, Bezdičková M. Filipčíková R, et al. Among authors: hlusi a. Ceska Gynekol. 2013 Jan;78(1):73-7. Ceska Gynekol. 2013. PMID: 23607386 Czech.

4

The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers.

Slavik L, Prochazkova J, Prochazka M, Simetka O, Hlusi A, Ulehlova J. Slavik L, et al. Among authors: hlusi a. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):333-7. doi: 10.5507/bp.2011.031. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22336645 Free article.

5

The Modern Pneumatic Tube System Transports with Reduced Speed Does Not Affect Special Coagulation Tests.

Slavík L, Úlehlová J, Bradáčová P, Chasáková K, Hluší A, Palová M, Entrová A. Slavík L, et al. Among authors: hlusi a. J Med Syst. 2020 Jul 21;44(9):142. doi: 10.1007/s10916-020-01614-6. J Med Syst. 2020. PMID: 32696269

6

Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.

Slavik L, Jacova J, Friedecky D, Ulehlova J, Tauber Z, Prochazkova J, Hlusi A, Palova M. Slavik L, et al. Among authors: hlusi a. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619872556. doi: 10.1177/1076029619872556. Clin Appl Thromb Hemost. 2019. PMID: 31523979 Free PMC article.

7

Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome.

Bradáčová P, Slavík L, Skoumalová A, Úlehlová J, Kriegová E, Manukyan G, Friedecký D, Piskláková B, Ullrychová J, Procházková J, Hluší A. Bradáčová P, et al. Among authors: hlusi a. Int J Mol Sci. 2022 Aug 11;23(16):8973. doi: 10.3390/ijms23168973. Int J Mol Sci. 2022. PMID: 36012233 Free PMC article.

8

Current Promising Biomarkers and Methods in the Diagnostics of Antiphospholipid Syndrome: A Review.

Bradacova P, Slavik L, Ulehlova J, Skoumalova A, Ullrychova J, Prochazkova J, Hlusi A, Manukyan G, Kriegova E. Bradacova P, et al. Among authors: hlusi a. Biomedicines. 2021 Feb 8;9(2):166. doi: 10.3390/biomedicines9020166. Biomedicines. 2021. PMID: 33567576 Free PMC article. Review.

9

Thrombin Generation Testing in Patients with Myelofibrosis.

Palova M, Slavik L, Hlusi A, Szotkowski T, Ulehlova J, Divoka M, Navratilova J, Papajik T. Palova M, et al. Among authors: hlusi a. Clin Lab. 2018 Sep 1;64(9):1373-1383. doi: 10.7754/Clin.Lab.2018.180204. Clin Lab. 2018. PMID: 30274004

10

Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.

Slavik L, Svobodova G, Ulehlova J, Krcova V, Hlusi A, Prochazkova J, Hutyra M. Slavik L, et al. Among authors: hlusi a. Clin Lab. 2015;61(8):1027-32. doi: 10.7754/clin.lab.2015.141207. Clin Lab. 2015. PMID: 26427148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters